Zhongyuan Zhang
Papers
4
Total Citations
64
H-Index
3
About
Zhongyuan Zhang is a urological surgeon and clinical researcher whose work sits at the intersection of robotic surgery innovation and advanced oncological imaging. He has emerged as a key contributor to the clinical validation of China's domestically developed KangDuo Surgical Robot (KD-SR-01) system, helping to establish its safety and efficacy across a range of urological procedures. His prospective studies on robot-assisted partial nephrectomy via the retroperitoneal approach — among the first of their kind with this platform — have garnered significant attention, accumulating nearly 50 citations and providing critical early-stage evidence for an emerging surgical technology. Beyond robotics, Zhang has made notable strides in prostate cancer diagnostics through his involvement in a pioneering first-in-human study of a dual-modality PSMA-targeted probe, enabling simultaneous preoperative PET/CT and intraoperative fluorescence imaging — a potentially transformative advance in surgical precision for prostate cancer. His participation in randomized controlled trials comparing the KangDuo system directly with the da Vinci platform further underscores his commitment to rigorous, evidence-based surgical research. Zhang's body of work reflects a dedication to advancing minimally invasive urology through both technological innovation and translational clinical science.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4